Zepeng Du

1.4k citations
53 papers · 1.1k indexed · h-index 18
Topics
Microbial metabolism and enzyme function (9 papers)S100 Proteins and Annexins (7 papers)RNA modifications and cancer (6 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaThe Journal of Immunology
Partner nations
ChinaUnited StatesCuba

In The Last Decade

Zepeng Du

53 papers receiving 1.0k citations

Peers

Zepeng Du
Comparison fields: 5 of 97
  • Molecular Biology 622
  • Cancer Research 257
  • Immunology 202
  • Cell Biology 125
  • Oncology 123
Replace Carl V. Hamby with:
Carl V. Hamby United States
Aintzane Asumendi Spain
Meena Sharma United States
Nina Fenouille France
Christine Prébois France
Shuhei Yoshida Japan
Ken‐ichi Kozaki Japan
Daqing Wu United States
Luciana P. Schwab United States
Zepeng Du relative to Carl V. Hamby United States Carl V. Hamby's profile →
Citations per field
00.5×4.5×
Carl V. Hamby · 1×
Citations per year

Countries citing papers authored by Zepeng Du

Since Specialization
Citations

This map shows the geographic impact of Zepeng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zepeng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zepeng Du more than expected).

Fields of papers citing papers by Zepeng Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zepeng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zepeng Du. The network helps show where Zepeng Du may publish in the future.

Co-authorship network of co-authors of Zepeng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Zepeng Du. A scholar is included among the top collaborators of Zepeng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zepeng Du. Zepeng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 6
3 1
4 1
5 9
6 1
7 15
8 7
9 13
10 9
11 25
12 28
13 25
14 8
15 47
16 2
17 25
18 49
19 56
20 4

About Zepeng Du

Zepeng Du is a scholar working on Cancer Research, Molecular Biology and Immunology and Allergy, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include Microbial metabolism and enzyme function (9 papers), S100 Proteins and Annexins (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (257 citations), Immunology and Allergy (96 citations) and Immunology (202 citations). Zepeng Du has collaborated with scholars based in China, United States and Cuba. Frequent co-authors include En‐Min Li, Li‐Yan Xu, Bingli Wu, Jian‐Yi Wu, Jian‐Jun Xie, Lian‐Di Liao, Xiu‐E Xu, Shirley S. Craig, A M Irani and Nancy Noben-Trauth. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026